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Abstract 
This study describes the distribution of intravenously injected polyacrylic acid (PAA) 
coated γ-Fe2O3 NPs (10 mg kg-1) at the organ, cellular and subcellular levels in healthy 
BALB/cJ mice and in parallel addresses the effects of NP injection on kidney function, 
blood pressure and vascular contractility. Magnetic resonance imaging (MRI) and 
transmission electron microscopy (TEM) showed accumulation of NPs in the liver within 
1h after intravenous infusion, accommodated by intracellular uptake in endothelial and 
Kupffer cells with subsequent intracellular uptake in renal cells, particularly the cytoplasm 
of the proximal tubule, in podocytes and mesangial cells. The renofunctional effects of 
NPs were evaluated by arterial acid-base status and measurements of glomerular filtration 
rate (GFR) after instrumentation with chronically indwelling catheters. Arterial pH was 
7.46±0.02 and 7.41±0.02 in mice 0.5h after injections of saline or NP, and did not change 
over the next 12h. In addition, the injections of NP did not affect arterial PCO2 or [HCO3-] 
either. Twenty-four and 96h after NP injections, the GFR averaged 11.0±0.8 and 13.0±0.4 
ml min-1 g-1, respectively, values which were statistically comparable with controls 
(14.0±0.2 and 14.0±0.6 ml min-1 g-1). Mean arterial blood pressure (MAP) decreased 12-
24h after NP injections (111.1±11.5 vs 123.0±6.1 min-1) associated with a decreased 
contractility of small mesenteric arteries revealed by myography to characterise endothelial 
function. In conclusion, our study demonstrates that accumulation of superparamagnetic 
iron oxide nanoparticles does not affect kidney function in healthy mice but temporarily 
decreases blood pressure. 
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Introduction 
In recent years, the vast clinical potential of nanomedicine has incited the 
development of various multimodality particles with distinct biological, physical and 
chemical properties useful for imaging, as well as various biomedical and therapeutic 
applications (Farokhad and Langer, 2006; Gu, 2007; Longmire et al., 2008; Liong et al., 
2008). Superparamagnetic iron oxide nanoparticles (NP) have been explored for targeted 
drug delivery, hyperthermia, tissue repair, cell sorting, and contrast agents for magnetic 
resonance imaging (Rosen et al., 2012; Jain, 2007; Gupta et al., 2007). The NPs are often 
chemically modified and synthesised to increase stability and safety. In contrast to 
conventional imaging agents, NPs are relatively stable in vivo, exemplified by the recent 
findings that quantum dots are retained in the body for 100 days (Choi et al., 2007) and 
even up to two years (Ballou et al. 2007). It is imperative, therefore, to study the specific 
distribution of magnetic NP to understand the specificity and long-term biodistribution 
profiles to access a better clinical efficiency and safety (Rosen et al., 2012). It has been 
shown that excessive release of free ions from NPs that may be toxic (Weir et al. 1984), 
lead to oxidative stress (Hussain et al., 2005; McCord 1996) and disturb liver metabolism 
(Wisse et al. 1991). In addition, cirrhosis and hepatocellular carcinoma can develop when 
the liver iron concentration exceeds 4 µg g-1 wet weight (Neuberger et al. 2005). Hussain 
et al. (2005) recently demonstrated that high concentrations of F3O4 NP in vitro reduced 
cell proliferation and caused cell death in rat liver cells. 
Inhalation of air-borne particular matter (PM) increases mortality and morbidity 
from pulmonary mediated cardiac arrhythmias (Samet et al. 1994; Zhu et al. 2008) that 
seems to be precipitated by disrupted autonomic cardiovascular regulation (Magari et al. 
2001). PMs are a complex mixture of organic and inorganic chemicals, including metals 
and particulates (Mo et al. 2009) and particularly the ultra–fine particles (UFPs) with an 
aerodynamic diameter less than 100 µm seem to elicit cardiorespiratory malfunctions 
(Stern and McNeil 2008). Recent human and animal studies show that inhaled UFPs 
swiftly enter the systemic circulation (Nemmar et al. 2001; Pope III et al. 2004), where 
they disturb myocardial or vascular endothelial cell function (Pope III et al. 2004; Dockery 
et al. 1993; Pekkanen et al. 2002) by generation of reactive oxygen species (ROS; Mo et al. 
2009). Nevertheless, the specific biological interactions leading to the possible 
cardiovascular effects of PM and UFP remain largely unknown (Pekkanen et al. 2002) 
precluding successful mitigation of their negative impact. Many of the NPs explored for 
biomedical use share some physicochemical properties with UFPs and are therefor also 
believed to have similar detrimental effects on the cardiovascular system (Oberdörster et 
al. 2002). 
Considerable research has been devoted to understand and characterize the 
distribution and accumulation of various metal and magnetic nanoparticles in healthy 
organs, but less attention has been drawn to elucidate renal effects following NP injection. 
It is known that engineered particles, such as iodinated contrast agents, can cause acute 
kidney injury (Byrd and Sherman 1979; Nash et al. 2002; Bruce et al. 2009; Cochran et al., 
1983) and the incidence of acute kidney injury caused by contrast administration is 
commonly referred to as contrast-induced nephrotoxicity (Nash et al., 2002). Intrarenal 
accumulation of NPs may lead to acute kidney injury (Byrd and Sherman 1979; Cochran et 
al. 1983; Bruce et al. 2009) followed by a more permanent renal failure (Toprak 2007), 
likely mediated by medullary hypoxia due to decreased renal blood flow, secondary to 
vasoconstriction, tubular obstruction, direct tubular toxicity and oxidative damage (Persson 
and Tepel 2006). Furthermore, Chen et al. (2006) observed that mice exposed to nano-
copper developed glomerulitis, degeneration and necrosis of renal tubules, and renal 
inflammation.  
The objectives of this study were to determine: a) the destiny of intravenously 
injected polyacrylic acid (PAA) coated γ-Fe2O3 particles at a clinical relevant dose (Ma et 
al., 2012) for hyperthermic cancer therapy with particular emphasis on the renal and 
hepatic accumulation, b) the renal function (systemic acid/base status and GFR) following 
exposure to these particular NPs and c) the effect of the NPs on cardiovascular functions 
(MAP and vascular contractility). 
 
 
Methods 
Experimental animals 
 BALB/cJ mice of both sexes (7-10 weeks) were purchased from Taconic or Harlan 
(Denmark) and transported to the animal facility at Department of Biological Sciences, 
Aarhus University. In total 104 mice were used divided into the following studies to 
address the a) distribution of polyacrylic acid (PAA) coated γ-Fe2O3 particles (MR n=9, 
TEM n=8), b) the renal function (systemic acid/base status n= 21 and GFR n=18), c) 
cardiovascular effects (MAP n=12 and vascular contractility, n=36). 
The mice used for GFR measurements were housed at the Biomedical Laboratory, 
University of Southern Denmark. At both institutions, mice were kept under standard light 
(12:12 dark-light) and temperature conditions with free access to rodent chow and tap 
water. Animal care followed the guidelines of the National Institutes of Health and the 
experimental protocol was approved by the Danish Animal Experiments Inspectorate. 
 
Magnetic resonance imaging 
 A clinical 1.5 T Phillips Achiva MRI system (Philips Medical Systems, Best, 
Netherlands) was used to visualize the in vivo distribution of NPs. NPs were administered 
directly to the tail vein 1 h (n=3) or 96 h (n=6) prior to MRI, while a third group of three 
mice received a sham injection of saline. All mice were euthanized with an over-dose of 
pentobarbital (10 mg kg-1) immediately before positioned in the scanner.  
The iron-containing NPs cause a dephasing of the nearby spins of water, thereby 
decreasing the signal intensity on a T2*-weighted images. Thus, we applied a standard 
T2*-weighted gradient-echo sequence using the following parameters: field-of-view = 
260x260 mm2, matrix = 384x384, 10 slices with a thickness of 1 mm, repetition time = 800 
ms, echo time = 20 ms, excitation angle = 90, and number of averages nt = 3. A spin-echo 
sequence, for T2 relaxation mapping, was applied: field-of-view = 260x260 mm2, matrix = 
384x384, 10 slices with a thickness of 1 mm, repetition time = 2000 ms, array of echo 
times = 20,40, 60, 80, 100, 120, 140, 160 ms, and number of averages nt = 2. 
All data were exported in DICOM format to the Mistar (Apollo Imaging 
Technology, Melbourne, Australia) and ImageJ (a public domain, Java-based image 
processing program developed at the National Institutes of Health) analysis software. 
Relaxometric analysis was used to generate parametric T2 map based on the acquired 
multi-echo spin-echo images. A global intensity profile was computed for all 10 slices, and 
NP accumulation was confirmed by reduction in signal intensity in kidney and liver 
regions.  
 
Transmission electron microscopy (TEM). 
  γ-Fe2O3 particles (10 mg kg-1) were given in the venous catheter in two 
experimental groups with different exposure duration (24h and 96h, n= 3 in each), while 
additionally two mice received saline and thereby served as controls. After 24h and 96h, 
respectively, the mice were deeply anaesthetised by intraperitoneal injections of 
pentobarbital (50 mg ml-1, 0.01 ml g-1) and perfused transcardially with a 2 % 
paraformaldehyde and 2.5 % glutaraldehyde fixative in a 0.1 M phosphate buffer (pH 7.4) 
for 5 min until all organs became pale. Liver and kidney were transferred to individual 
glass vials with the fixative and subsequently post fixated in 4% osmium tetroxide 
dissolved in milli Q water. After 24 h, the tissue blocks were dehydrated in a series of 
increasing concentrations of ethanol (70, 90, 96 and 99.9 %), immersed in the organic 
intermedium propylene oxide and embedded in EMBed-812 (Electron Microscopy 
Sciences, Hatfiled, PA). Ultrathin sections for TEM were cut on a Leica Ultracut UCT 
ultramicrotome (Leica Mikrosysteme GmbH, Vienna Austria) with a 45 degrees angled 
diamond knife (Diatome, Biel, Switzerland). The ultrathin sections were stained with 
uranylacetate and inspected in a CM 100 FEI transmission electron microscope (FEI, 
North America NanoPort, Hillsboro, Oregon 97124, USA) and photographed with a CCD 
camera (1K MegaView, Olympus Soft Imaging Solutions GmbH, Münster, Germany), 
followed by image processing in AnalySIS (Olympus, Germany). 
Electron Energy Loss Spectroscopy (EELS; Gatan Quantum SE/963 spectroscope 
and camera (Gatan, Inc. Pieasanton, CA 94588) on a Titan Krios 80-300 microscope ( FEI, 
North America NanoPort, Hillsboro, Oregon 97124 USA)) were used to determine the 
elemental constitution of the particles imaged in TEM. The presence of the Fe2O3 in the 
particles was evaluated by comparing the position of the Fe-L2 and Fe-L3 edges in the 
obtained EELS spectrum with the positions of Fe-L2 and Fe-L3 edges from Fe2O3 in the 
EELS Atlas. A 30 eV slit was applied for acquisition of pre-edge (slit center 683 eV) and 
post-edge (slit center 728 eV) images. Jump-ratio was calculated from these recordings 
using Gatan software. The size of the particles was measured using ImageJ on the TEM-
images from the for EELS analysis. 
 
 
Insertion of arterial and venous catheters for GFR measurements 
 The eighteen mice used for determination of glomerular filtration rate (GFR) 
measured by inulin clearance, were anaesthetised by an intraperitoneal injection of a 
combination drug (Ketalar/Rompun or Ketamin/Xylazine). Chronic indwelling catheters 
were placed in the femoral artery and vein for measurements of arterial blood pressure and 
venous infusions, respectively (Mattson, 1998). Micro-Renathane Tubing MRE-040 and 
MRE-033 (AgnTho’s AB; Sweden) were used as catheter tips. The catheters were 
exteriorized through a subcutaneous tunnel from the groin to the neck where additionally a 
lightweight tethering spring to a steel button in the neck was implanted. Following the 
operation, the spring containing the catheters was secured to a swivel above the cage 
enabling the mice to move unrestrained. To maintain catheter patency, a continuous 
infusion of 10 µl h-1 of heparin diluted isotonic glucose to 100 IU ml-1 was started in the 
arterial side. Twice within the first 24h after surgery, the mice were given subcutaneous 
injections of Temgesic for analgesia (Buprenorphinum, 0.3 mg ml-1, 3.75 mg kg-1). The 
mice were allowed to recover for four days before the experiments were conducted.  
The actual experiments were initiated by connecting the arterial line to a pressure 
transducer (Föhr Medical Instruments, Hessen, Germany), and data were collected at 200 
Hz using Lab View software (National Instruments, Austin, TX, USA). 
 
Glomerular filtration rate (GFR) 
Four days after surgery, the mice had fully recovered and no change in blood 
pressure or heart rate was observed the following days. Basal blood pressure was measured 
for 1h before a consecutive 100µl bolus infusion of NP in nine mice through the venous 
catheter. As control, 100µl bolus infusion of saline was given to another nine mice. 
Initially, a 50µl isotonic bolus was given to place the saline in the dead space of the 
catheter. Inulin (Inutest 25%) was infused at the venous side at 10 µl h-1 for 24 and 96 
hours to achieve steady state. Then a small blood sample (100 µl) was withdrawn from the 
arterial catheter at both time points. 
 Plasma Inulin concentration was determined by Atomic Absorption Spectrometry. 
The plasma samples were diluted six times in 10 mM Na-Pi suspension (pH 5.0) and 
incubated with 50 µl inulinase pr 50 µl sample for at 37 °C for 10 min. Then 130 µl 
SDH/NADH was added and the suspension was further incubated for 60 min. The 
absorbance was determined at the wavelengths at 340-490 nm. GFR was calculated as 
inulin infusion rate / plasma inulin concentration. 
 
Insertion of arterial for blood sampling 
To sample arterial blood from undisturbed mice, catheters were inserted into the left 
carotid artery. Catheters were also inserted in the left jugular vein for injection of NPs in 
some experiments. During surgery, the mice were anaesthetised with an intraperitoneal 
injection of ketamine and xylazine (75 and 10 mg kg-1, respectively; 0.01 ml g-1 mouse). A 
small thermometer was inserted into the rectum, so that body temperature could be 
maintained at 36-37.5 °C throughout surgery.  
Under a dissecting microscope (Olympus, SZ-STB1, Japan), the left carotid artery or 
the left jugular vein were cannulated with stretched PE-10 tubing (Portex fine bore 
polythene tubing, Smiths Medical ASP, Inc., Keene, USA) containing heparinized saline 
(50 IU/ml, 0.9 % NaCl). The catheter was led through a small incision in the back of the 
neck, exteriorized behind the ear and secured to the skin by a single stitch. All mice 
received a subcutaneous injection of 1 ml saline to prevent dehydration. The mice were 
allowed to recover for at least 24 h at 32°C after surgery and received two subcutaneous 
injections of Temgesic for analgesia (Buprenorphinum, 0.3 mg ml-1, 3.75 mg kg-1).  
 
Arterial blood gases 
Acid-base parameters were measured 30 min, 3h and 12h after NP had been 
administrated through the tail vein (n=8 in all groups). In each group, four mice received 
NPs while the other four received saline injected through the tail vein. To measure blood 
gases, a 300 µl of arterial blood was taken through the catheter of undisturbed mice.  
Blood pH was measured with a Radiometer (Copenhagen, Denmark) capillary pH 
electrode thermostated to 37oC and connected to a Radiometer PHM 73. Total plasma CO2 
concentration ([CO2]pl) was measured as described by Cameron (Cameron, 1971), and 
plasma bicarbonate concentration ([HCO3-]pl) was calculated as [CO2]pl – (αCO2 x PCO2), 
using a plasma CO2 solubility (αCO2) at 37°C of 0.0301 mmol l-1 mmHg-1 (Siggaard-
Andersen (1976). 
Plasma [HCO3-] was calculated from pH and total plasma [CO2]pl using the 
Henderson–Hasselbalch equation. The CO2 solubility coefficient of 0.0301 mmol l-1 
mmHg-1 was taken from Siggaard-Andersen (1976) and pK′ was considered to be 7.816 
±0.234pH (Iversen et al., 2012). Haematocrit was measured in duplicate after centrifuging 
blood in micro-haematocrit tubes at 12·000·r.p.m. for 3·min. 
 
Surgical implants of telemetric probes 
Surgical anaesthesia was induced by an intraperitoneal injection of ketamine (75 
mg kg-1) and xylazine (10 mg kg-1). A small thermistor was inserted into the rectum to 
maintain body temperature at 36-37.5 °C throughout surgery, and the eyes were protected 
against dehydration with an eye ointment (Ophtha A/S, Copenhagen, Denmark). After the 
neck had been shaved and disinfected, the mouse was placed in a supine position and a 
ventral midline skin incision was made from the lower mandible posteriorly to the sternum 
(3 cm). The sub-maxillary glands were gently separated and the left common carotid artery 
was isolated using fine forceps, without disrupting the vagus nerve parallel to the artery. 
Two sterile silk sutures (6-0, Agnthos, Sweden) were passed under the vessel for 
temporary occlusion of the artery during catherisation and to secure the catheter. The 
catheter from the telemetric probe (TA11PA-C10: 1.1 cm 3, 1.4 g; Data Sciences 
International (DSI), St Paul, MN, USA) was inserted into the artery, and a subcutaneous 
pouch was formed for placement of the transmitter body along the animal’s right flank. 
The neck incision was closed using 5-0 silk. Mice were allowed to recover from surgery in 
a climate chamber at 28 ºC the first 24h after surgery. Twice within this re-covalence 
period, the mice received subcutaneous injections of Temgesic for analgesia 
(Buprenorphinum, 0.3 mg ml-1, 3.75 mg kg-1).  
 
Telemetry protocol 
Following recovery from surgery and anesthesia, the 12 mice instrumented with the 
telemetric blood pressure probes were returned to their cages (placed on top of the 
telemetry receivers), and monitored daily throughout the study. Radio telemeters (Data 
Sciences International (DSI), St Paul, MN, USA) were magnetically activated 7 days after 
surgery, and blood pressure (pulsatile waveforms and mean arterial pressure, (MAP)), 
heart rate, and locomotor activity were recorded continuously as 10 sec averages each min 
for 7 days. After recording cardiovascular parameters for 24h, NP (γ-Fe2O3) or saline were 
injected in the tail vein. The telemetered pressure signals (absolute pressure) were 
corrected automatically for changes in atmospheric pressure measured by an ambient 
pressure monitor. 
 
Isometric force measurements in mesenteric small arteries 
Thirty-six mice of both sexes were infused with either NPs or saline in the tail vein 
and mesenteric arteries were removed at different time points for in vitro studies. Mice that 
received γ-Fe2O3 (100 µl; 10 mg kg-1) were killed after 24 h, 72h and 7 days (n=6 in each 
groups), respectively, while control animals having received saline were killed at the same 
points in time as the treated mice. Twelve of the arteries harvested from the control group 
were exposed to γ-Fe2O3 NPs (10 or 50 mg kg-1) for 30 min in vitro. 
In all mice, the mesenteric bed was carefully pinned out in a Petric dish and four 2 
mm long segments of third-order branches were dissected free from fat and connective 
tissue (Mulvany et al., 1978). The isolated arteries were threaded onto two stainless steel 
wires (40 µm in diameter) and mounted as ring preparations in a quadruple wire myograph 
(Model 610M, Danish Myo Technology, Aarhus University) for isometric force 
measurements. Data were sampled at 100 Hz (16 bit) using a Biopack MP100 data 
acquisitions system (Biopac system Inc. Santababara, CA, USA). Upon mounting, the 
arteries were allowed to equilibrate for 20 min before they were stretched stepwise to 
characterize the passive elastic properties (Mulvany and Halpern, 1977). The mesenteric 
arteries were stretched to 90 % of L100, where L100 is defined as the circumference of the 
relaxed artery at a transmural pressure of 100 mmHg. Prior to the experimental protocol, 
the arteries were stimulated three times with 10µM noradrenaline (NA) dissolved in 125 
mM K+-containing physiological saltwater solution (PSSS (KPSS)) for 3 min to verify 
viability. Subsequently, NA (3x10-3) was added and at the maximal response, a single dose 
of acetylcholine (ACh; 1 µM) was given to ensure relaxation of the vessel. This was 
repeated with an increased dose of Ach to 3 µM. Vessels that failed to contract more than 
125 % of the forced developed at L100 were discarded. Both NA and ACh were added 
directly to the bath. To evaluate the contractile properties, we constructed cumulative NA 
concentration-response curves (0.1-0.3 µM NA), increasing the concentration every 2 min 
to allow the force to reach a steady state. 
The vessels were dissected, mounted and, if not indicated otherwise, held relaxed in 
physiological salt solution (PSS) of the following composition in mM: NaC1, 119; 
NaHCO3, 25; KC1 4.9; CaC12, 2.5; H2PO4, 1.18; MgSO4, 1.17; EDTA, 0.026, and glucose 
11. KPSS was PSS in which Na+ was substituted by an equimolar concentration of K+ to 
reach 15 mM K+. All solutions were bubbled with 5% CO2 in O2 at 37oC and pH was 
adjusted to 7.4 immediately before use. 
 
 
Figure 1 Characteristics of the γ-Fe2O3 NP synthesized for this study. A: Transmission electron 
microscopy (TEM) image of uncoated γ-Fe2O3 NP particles, B: Size distribution of γ-Fe2O3 NP 
nanoparticles obtained by TEM. The continuous line is a log-normal function with median 
diameter 6.8 nm and polydispersity 0.18, C: Magnetic field dependence of the macroscopic 
magnetization normalized by its saturation value for a 10 wt.% g-Fe2O3 dispersion. The solid curve 
results from the convolution between the Langevin equation for paramagnetism and a log-normal 
function with median diameter 6.7 nm and polydispersity 0.21. 
 
Nanoparticles  
Nano-sized γ-Fe2O3 coated with poly(acrylic acid) 2000 g mol-1 (PAA2K) 
(Laboratoire Matière et Systèmes Complexes, Université Denis Diderot Paris-VII) were 
used in this experiment (Fig. 1). The synthesis of iron oxide nanoparticles (γ-Fe2O3, 
maghemite) was based on the polycondensation of metallic salts in alkaline aqueous media 
(Massart et al., 1995). A transmission electron microscopy (TEM) image obtained from a 
dilute aqueous dispersion exhibited compact and spherical particles (Fig. 1 A). The size 
distribution of these particles was described by a log-normal function with a median 
diameter 𝐷𝐷 = 6.8  𝑛𝑛𝑛𝑛  and polydispersity of 𝑠𝑠 = 0.18  (Fig. 1 B). The 
polydispersity is described as the ratio between standard deviation and the mean value. 
Vibrating sample magnetometry (VSM) was carried out to determine the magnetization 
versus excitation from a dispersion at concentration 10 wt. %. Fig. 1 C shows the evolution 
of the macroscopic magnetization 𝑀𝑀(𝐻𝐻) normalized by its saturation value 𝑀𝑀. The solid 
line in grey was calculated using the Langevin function of paramagnetism convoluted with 
a log-normal distribution function of the particle sizes. The parameters of this distribution 
were 𝐷𝐷 = 6.7  𝑛𝑛𝑛𝑛 and 𝑠𝑠 = 0.21, in good agreement with the those obtained by 
TEM. Further characterization of the particles including the determination of the surface 
charge and structural anisotropy can be found in our previous work (Berret et al., 2007). 
To improve their colloidal stability, the cationic particles were coated with MW = 2000 g 
mol-1 poly(acrylic acid) using the precipitation-redispersion process. This process resulted 
in the adsorption of a highly resilient 3 nm polymer layer surrounding the particles. The 
hydrodynamic diameters of the bare and coated NPs were 12.7 and 17.7 nm, respectively 
(Berret et al., 2007; Chanteau et al., 2009; Safi et al., 2010; 2011). 
 
Statistical analysis 
Data were tested for homogeneity of variance and normal distribution prior to 
parametric tests. Statistically significance of differences between treatments on blood 
pressure and heart rate obtained in mice receiving PAA coated γ-Fe2O3 NP or saline were 
evaluated by a two-factor (time and treatment) analysis of variance (ANOVA) for 
repeated-measures followed by a Tukey multiple-comparison (Sigmaplot and Statistic 
11.0). Effects of treatment with NP and the time period exposure on GFR were tested by a 
t-test. Differences between means were considered statistically significant when P≤0.05 
and all results are presented as means ± S.E.M. 
The telemetry data were collected continuously by sampling for 10 sec every 
minute and stored using the Dataquest ART data acquisition system (Data Sciences 
International). After the experimental session, the obtained data was uploaded into the 
ACQ analysis program (Data Sciences International) and exported into Excel. The data 
from the myograph was collected at 50 Hz and transferred directly into Excel. All further 
data analyses from both experimental sessions were analyses in Excel. Data were tested for 
homogeneity of variance and normal distribution prior to parametric tests. Statistical 
significance of differences between treatments on blood pressure, heart rate or locomotor 
activity obtained in mice receiving PAA coated γ-Fe2O3 NP or saline was evaluated by a 
two-factor (time and treatment) analysis of variance (ANOVA) for repeated-measures 
followed by a Tukey multiple-comparison. In the myograph studies, the effect of 
treatment, i.e. PAA coated γ-Fe2O3 NP or saline and the cumulative dose-response curve of 
noradrenalin on tension and pressure was also evaluated by a two-factor (noradrenalin and 
treatment) analysis of variance (ANOVA) for repeated-measures followed by a Tukey 
multiple-comparison. Differences between means were considered statistically significant 
when P≤0.05 and all results are presented as means ± S.E.M. 
 
 
Results  
The overall distribution of the intravenously injected PAA coated γ-Fe2O3 NPs 
(Fig. 1) in healthy mice was revealed by MRI (Fig. 2). Because these particles are 
magnetic, they disturb the local magnetic field in the tissue. Therefore, the accumulation of 
NPs is indirectly recognized as decreased signal intensity in the MRI images. The 
accumulation of PAA coated γ-Fe2O3 NPs was visible in the liver within 1h after 
intravenous infusion (Fig 2 B) and subsequent accumulation in kidney and spleen 3h after 
injections (Fig 2 C, F). This distribution pattern did not change over the next 96h (Fig. 2 C, 
F). Transmission Electron Microscopy (TEM) confirmed the presence of these NPs in the 
liver and kidney. The particles were very clearly present in vesicles, most likely belonging 
to the endocytic/lysosomal system, in the cytoplasm of endothelial (Fig 3 A and B) and 
Kuppfer cells in the liver sinusoids (Fig. 3 C and D). In the kidney, the TEM images 
showed the NPs to be present in vesicles in the cytoplasm most likely belonging to the 
endocytic/lysosomal pathway in podocytes (Fig. 4 A, B, C and D), proximal tubule cells 
(Fig. 4 E and F), and mesangial cells (not shown). Electron Energy Loss Spectroscopy 
(EELS) showed edges at positions consistent with Fe-L2 and Fe-L3 edges from Fe2O3 
(Fig. 5 A and B). The diameter of the particles was 6.24± 0.18 nm (n = 30). Jump-ratio 
analysis confirmed the Fe specific edges to origin from the particles (Fig. 5 C, D and E). 
These results confirms that the particles imaged by TEM consist of Fe2O3, and thus to be 
the injected NPs. 
 
Arterial acid-base status 
To assess whether the NP deposition in the kidneys (Fig. 2, 4), particularly 
proximal tubular cells, would affect or disturb normal arterial acid-base status, we 
measured arterial pH, PCO2 and [HCO3-] at 0.5h, 3h and 12h after intravenous injections of 
γ-Fe2O3NP or saline (Table 1). Arterial pH was statistically similar 0.5h after injections of 
saline or NP in mice (7.46±0.02 and 7.41±0.02 respectively). These values remained 
unchanged over the next 12h. Injections of NP did not affect PCO2.  There was a slight (but 
statistically insignificant) tendency of decrease in [HCO3-] 3h after injections of NP (Table 
1), but the concentration after 12h was similar to the 0.5h experimental group. In 
conclusion, neither pH, PCO2 nor [HCO3-] were affected of saline injections or 
significantly different from the experimental groups receiving NP. 
 
 
Figure 2 Magnetic resonance imaging of the distribution of intravenously injected PAA coated γ-
Fe2O3 NP (10 mg kg-1) A: representative control mouse, B: 1h after NP administration, liver, C: 
96h after administration, liver, D: representative control mouse, E: 1h after NP administration, 
kidney, C: 96h after administration, kidney. Since the present NPs are magnetic, they will disrupt 
the magnetic signals in the MR scanner, where as NP build up are seen as dark areas. 
 
 
 
Figure 3 Transmission electron microscopy (TEM) of PAA coated γ-Fe2O3 NP accumulated in the 
kidney. The NPs are seen as small dark spots. BB: Brushborder, L: Lysosome, EC: endothelial cell, 
M: Mitochondria, RBC: Red blood cell, PC: Podocyte, GBM: glomerular basal membrane, NP: 
Nanoparticles  
  
Figure 4 Transmission electron microscopy (TEM) of PAA coated γ-Fe2O3 NP accumulated in the 
kidney. The NPs are seen as small dark spots. BB: Brushborder, L: Lysosome, EC: endothelial cell, 
M: Mitochondria, RBC: Red blood cell, PC: Podocyte, GBM: glomerular basal membrane, NP: 
Nanoparticles  
 
 
Figure 5 Electron Energy Loss Spectroscopy (EELS) confirmed the dark spots accumulating in the 
liver and kidney to be γ-Fe2O3 NP. A: Transmission electron microscopy picture of the evaluated 
sample. B: EELS spectrum from the sample with indications of the position of the Fe-L2 and Fe-L3 
and the position of the pre-edge and post-edge slit recordings. The edges in the EELS spectrum are 
consistent with Fe being the atom resulting in the electron energy loss. C: Image showing the 
positional origin in the sample of electrons in the pre-edge energy window. D: Image showing the 
positional origin in the sample of electrons in the post-edge energy window. E: Image showing the 
jump-ratio, indicating the positional origin of the Fe specific electrons in the sample. These results 
confirm the imaged particles to be the injected NP's 
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Mean arterial blood pressure (MAP) measured by fluid-filed catheters 
The resting mean arterial pressure (MAP) measured prior to PAA coated γ-Fe2O3 
NPs or saline IV injections, respectively, averaged 124.1±3.8 and 117.3±3.7 mmHg and 
the heart rate (fH) 606±11 and 577±12 min-1. NP injections caused a significant decrease in 
MAP (103.7±5.0 and 99.4±4.5 mmHg) 12-24h after administration (Fig. 6). This was 
associated with a tendency towards a decreased fH, although this was not significant 
(483±64 and 487±58 min-1). After 36h, both blood pressure and heart rate were restored. 
 
Figure 6 Mean arterial blood pressure (MAP) and heart rate in healthy BLAB/c mice receiving 
PAA coated γ-Fe2O3 NP (10 mg kg-1). The NPs were given at time 0. The filled circles represent 
control mice that received saline (n=9) where as the open circles represents mice that received NP 
(n=9). Asterisks (*) denote a significant difference (p < 0.05) compared to the control group. All 
data are shown as mean±SEM.  
 
Figure 7 Glomerular filtration rate (GFR) measured in two groups of mice receiving PAA coated 
γ-Fe2O3 NP (grey bars, n=9) and control mice (black bars, n=9) determined 24h and 96h after NP 
administration. Data are shown as mean±SEM. 
 
 
Glomerular filtration rate (GFR) 
TEM of the kidney revealed NP to accumulate in the mesangial cells and 
podocytes. Since these cells play pivotal roles in determining the glomerular filtration rate 
(GFR), which is the classically used parameter to evaluate overall kidney function, we 
determined GFR in mice subjected to NP injections. The mice received intravenously 
injected PAA coated γ-Fe2O3 NPs following 24 and 96h. GFR was 11.0±0.8 and 13.0±0.4 
ml min-1 g-1 following 24 and 96h of NP injections, and was not significantly different 
from the values obtained in mice receiving saline, serving as control group (14.0±0.2 and 
14.0±0.6 ml min-1 g-1; Fig. 7).  
 
Telemetric blood pressure measurements 
The example of continuous measurements of mean arterial blood pressure (MAP), 
heart rate (fH), and physical activity obtained 8 days after surgery (Fig. 8) reveal the typical 
murine circadian rhythms with elevated and more variable MAP, fH and activity during 
dark periods. To account for diurnal rhythms and activity-related changes, the data for 
MAP and fH were analyzed in different ways; i) the average model, and ii) the model 
proposed by Van Vliet et al. (2006) excluding the effect of light and activity. 
 
Figure 8 Representative 36h data trace from one healthy BALB/c mouse 10 days after 
instrumentation. A: Mean arterial blood pressure (MAP), B: heart rate (fH), C: locomotor activity. 
The dotted lines indicate the shift from light to dark-phases, respectively. 
 
Figure 9 presents the data analyzed with the first method when MAP, fH and 
activity were determined as the average of the three lowest values for each experimental 
group. Data are presented separately for the 12h light periods over the seven experimental 
days (left-handed panels) and the 12h dark periods (right-handed panels). In both the NP-
treated group and the control group, MAP tended to decrease during the light periods (Fig. 
9 A), although not statistically significant. MAP was not affected of time after treatment in 
either the control group receiving saline or in the mice, which received NP. Similar to 
MAP, fH was generally not affected by NPs (Fig. 9 C, D). In both groups, both during light 
and dark phases, there was a tendency, although insignificantly, of decreased fH over the 7 
days. There was no effect of NP injections on locomotor activity (Fig. 9 E ,F). 
 In the second analysis, we used the method of Van Vliet et al (2006) to calculate 
average MAP as:  
MAP24h = MAPinactive + Tactive (MAPactive – MAPinactive), 
to exclude the effect of circadian rhythms and activity on MAP (e.g. Figs 8), where 
MAP24h represents mean MAP over the entire 24 h period, MAPinactive and MAPactive the 
MAP during inactivity (no activity signal) and activity, respectively. Tactive represents the 
proportion of time spent in activity. By emphasizing the impact of activity, the calculated 
MAP depends on  (i) the extent of the change in Tactive and (ii) the magnitude of the effect 
of activity on MAP (MAPactive – MAPinactive) (Van Vliet et al. 2006). Figure 10 shows data 
from the present study analyzed based on this method. When compensating for activity 
level, there was a significant reduction in MAP on the second and seventh day after 
intravenous injection of γ-Fe2O3 NPs, while here was no observed effect of injecting 
saline.  
 
Figure 9 Mean arterial blood pressure (MAP), heart rate (fH) and activity of the two experimental 
groups of healthy BALB/c mice that received PAA coated γ-Fe2O3 NP (∆:-:0?-85:1G:

Data are presented as mean±SEM. 
 
Contractile properties of mesenteric vessels in vitro 
Since no renofunctional effects were seen in mice receiving NP injections, the drop 
in MAP observed prompted us to investigate the vascular contractility. All mesenteric 
arteries exhibited a concentration-dependent contraction in response to noradrenaline 
(NA). However, the maximal response to NA was significantly lower in arteries from mice 
injected with iron oxide NP and in vitro treated vessels at the lowest dose. Furthermore, the 
maximal response to NA tended to decrease at the highest dose of γ-Fe2O3  (Fig. 11 A). 
This was similar to the mesenteric vessels from mice that received γ-Fe2O3 NPs 24 and 72 
h prior to the myograph measurements, whereas vessels from mice exposed to iron oxide 
for 7 days did not differ from control mice (Fig. 11 B, C, D). In addition, the maximal 
force developed in the γ-Fe2O3 NPs in vitro protocol significantly failed to develop as high 
as the value obtained in the control groups (Fig. 11 A). There was only an effect of γ-Fe2O3 
NPs in vivo exposure on pressure development after 24h of exposure (Fig. 12 B, C, D). 
 
Figure 10 Mean arterial blood pressure (MAP) in the two experimental groups of mice that 
received PAA coated γ-Fe2O3 NP (∆:-:0?-85:1G:
/-8/A8-@102>;9,-:,851@1@-8

-:0C41:0-@-C-?:;>9-85?10@;@41/;:@>;8B-8A15:1-/43>;A<
-@- are presented 
as mean±SE. Asterisks (*) denote a significant compared to the control group, dobble dagger (‡) 
indicates significant difference (p < 0.05) between the two treatment groups. 
 
 
Figure 11 Cumulative dose-response curves of tension of small mesenteric arteries from healthy 
BALB/c mice after receiving PAA coated γ-Fe2O3 NP (∆ -:0 ?-85:1 G @; 5:/>1-?5:3
/;:/1:@>-@5;:?;2:;>-0>1:-85:1 &
 5:B5@>; ?@A0EC5@4γ-Fe2O3 &(: 5:@>-venous 
injected PAA coated γ-Fe2O3 NP (∆-:0 ?-85:1 G 2;>4 :4 :-:0
0-E? :
 ?@1>5?7?  01:;@1 - ?53:525/-:@ 05221>1:/1 < < 0.05) compared to the control 
group. Data are presented as mean±SEM.  
  
Figure 12 Cumulative dose-response curves of pressure development of small mesenteric arteries 
from healthy BALB/c mice after receiving PAA coated γ-Fe2O3 NP (∆-:0?-85:1G@;5:/>1-?5:3
/;:/1:@>-@5;:?;2:;>-0>1:-85:1 &
 5:B5@>; ?@A0EC5@4γ-Fe2O3 NP (n= 5:@>-B1:;A?
injected PAA coated γ-Fe2O3 NP (∆) and saline (2;>4:2;>4:-:0
2;>0-E?:
?@1>5?7?01:;@1-?53:525/-:@05221>1:/1< < 0.05) compared to the control 
group. Data are presented as mean±SEM. 
 
 
Discussion 
In agreement with previous studies, the PAA coated γ-Fe2O3 NPs (Fig. 1) 
accumulated rapidly in liver upon intravenous injection, followed by a slower, but 
pronounced accumulation in the kidneys (Fig. 2 B, F). This temporal pattern of iron oxide 
NP seems to be independent of size, coatings, and route of administration (Briley-Saebo et 
al., 2004; Jain et al., 2007; Zhu et al., 2008; Thakor et al., 2011). In our study, the NPs in 
the liver were not incorporated in the hepatocytes, but appeared very clearly in both 
endothelial and Kupffer cells in the liver sinusoids. Given the generally very high 
permeability of the endothelial cells in liver sinusoids, it is surprising not to see NPs in 
hepatocytes. However, this indicates that the Kupffer cells and endothelial cells of liver 
sinusoids perform a filtering function, which may protect the hepatocytes from particles. 
Previous studies have also shown that iron oxide particles are phagocytized or endocytized 
by the immune cells of the reticular endothelial system (RES) in liver, spleen, lymph and 
bone marrow (Wisner et al., 1995; Chouly et al., 1996; Rety et al., 2000; Allkemper et al., 
2002). However, despite the rapid accumulation of NPs in macrophages and clearance by 
the RES system, the particles may cause temporary inflammation and apoptosis in the liver 
(Thakor et al., 2011). Furthermore, the TEM images showed that the PAA coated γ-Fe2O3 
NPs appeared in vesicular structures of mesangial cells, podocytes and proximal tubular 
cells within the kidney (Fig. 4). When the same PAA coated γ-Fe2O3 NPs are incubated in 
lymphoblast cells in vitro, the NPs were absorbed onto the membrane and in the cytoplasm 
in the membrane bound compartments (Safi et al., 2011). In our study, NPs were not found 
in the cytosol or in the nucleus. The slow accumulation in the kidney in spite of efficient 
build up in liver endothelial and Kuppfer cells may reflect an iron NP overload of the 
hepatic RES.  
Because of the buildup of the PAA coated γ-Fe2O3 NPs in podocytes, we 
investigated whether the metal NP may affect kidney function. It has been discussed 
whether the kidneys excrete intravenously injected NPs, by either glomerular filtration 
and/or tubular excretion (Longmire et al., 2008). Neither mesangial cells nor podocytes has 
direct access to NP's in blood plasma, so the presence of NP's in these cells show that the 
NP's pass the endothelial lining of the glomerular capillaries. These endothelial cells are of 
the fenestrated type, and may thus allow NP's to pass to the interstitial space, and be 
accessible to mesangial cells. The presence of NPs in podocytes moreover indicates that 
NPs can pass the glomerular basement membrane, and thus are filtered into the urine. This 
is further supported by the finding of NPs in endocytic vesicles/lysosomes in the cytoplasm 
of proximal tubular cells. The proximal tubule connects Bowman’s capsule to the loop of 
Henle and is of major importance for reclamation of filtered salt, water, bicarbonate, 
glucose and proteins as well as for secretion of organic acids, such as creatinine and other 
bases. In spite of the NP accumulation in this part of the kidney tubules, there was no 
disturbance of plasma [HCO3-] or arterial acid-base balance upon intravenous injections of 
NP. Thus, it seems that the accumulated NPs do not affect renal acid-base regulation. The 
control values for plasma [HCO3-] as well as arterial pH and PCO2 were similar to previous 
measurements on chronically instrumented mice (Wall et al., 2004; Chambrey, 2005; 
Vallet, 2006; Hafner et al., 2008; Iversen et al., 2012). Importantly, we also demonstrated 
that the accumulation of iron oxide NPs in the kidneys did not affect GFR (Fig. 7). This 
indicates that despite NP accumulation in podocytes and glomerular mesangial-cells, the 
essential functions of these cells in regulation of GFR are still intact.  
Cardiovascular effects 
Although exposure to ultrafine particles (UFP; less than 1 µm) with similar 
physiochemical properties as NPs is known to cause adverse cardiovascular effects, 
(Hamor et al., 2003; Pope et al., 2002, 2004; Stern and McNeil, 2008) only a few previous 
studies have addressed the question of how engineered NPs affect the cardiovascular 
system (Apte and Hede, 2007; Pope et al., 2004). In our study, the transient decrease in 
MAP at 12-24h after NP administration (Fig. 6, 10) may be associated with endothelial 
dysfunction due to oxidative stress as hypothesized by Mo et al. (2009) and further may be 
explained by the uptake of NP in endothelial cells demonstrated in the present study (Fig. 3 
A, B). Telemetry allows for MAP to be measured accurately under relatively stress-free 
conditions in freely moving, conscious animals, thus alleviating the effects of stress from 
recent anesthesia and surgery (Butz and Davisson, 2001). The circadian rhythms in MAP, 
fH and activity level were similar to previous studies using telemetry in mice Van Vliet et 
al., 2006) and in accordance with these studies, we also found pronounced individual 
variation. The rise in MAP during activity appears to be sympathetically mediated (Swoap 
et al., 2004) and locomotor activity is considered to be the major determinant of the 
variation in MAP amongst individuals. This may explain the significantly elevated MAP 
during the dark periods in mice receiving γ-Fe2O3 NPs.  
We have demonstrated that acute decrease in MAP followed γ-Fe2O3 NPs 
injections. The effects of the injected NP on MAP are consistent with previous reports on 
inhalation of UFPs, as well as inhaled and injected NPs (Pope et al., 2004). Intravenous 
injections of gold nanoparticles in rats lead to a decreased QRS complex and increased 
time period between two repolarisation phases (Apte and Hede, 2007). In comparison, 
Albini et al. (2010) showed that single-wall carbon nanotubes were easily taken up by 
endothelial cells in vitro and were associated with an enhanced acidic vesicle compartment 
within the cells. In the myograph study addressing the endothelial function after NP 
administration, small mesenteric arteries from healthy mice incubated with PAA coated γ-
Fe2O3 NP in vitro developed a reduced maximal forced in response to increasing 
concentrations of noradrenaline. Similarly, small mesenteric arteries from mice, which had 
received the iron oxide NPs for 24h in vivo had a reduced maximal force of contraction, 
whereas there was no effect on the endothelial function after 7 days of NP exposure. In 
comparison, Apte and Hede (2007) showed that intravenous injections of gold NP (1 µg 
kg-1) caused mild bradycardia in rats with fH decreasing from 413 to 387 min-1 at a dose 
one to tenth of the suggested dose for normal clinical settings. However, other theories 
have been presented to explain these cardiovascular effects of UFP's. Instillation of single-
walled carbon nanotubes (SWCNTs; 1 µg g-1) affected autonomic control of blood 
pressure following four weeks of telemetric measurements in rats. This finding was 
ascribed to induction of a peculiar inflammatory pulmonary reaction (Legramante et al., 
2009). In a similar study, Thakor et al. (2011) reported no change in ECG, MAP or heart 
rate two weeks after intravenous or intraperitoneal administration of Raman-silica-gold-NP 
(R-Si-Au-NP; 200 µl of stock solution with 9.6 * 1010 NP). The cardiovascular parameters, 
however, were only reported on a weekly basis in the study of Thakor et al, (2011). In our 
study, the transient reduction in MAP was only observed at 12-24 h, and thus would not 
have been identified in the study by Thakor et al. (2011). We find it likely that the NPs are 
rapidly removed from the systemic circulation by the RES thereby limiting the potential 
toxic effects. The rapid uptake of NPs in the liver RES cells shown in our study may result 
from the transient hypotension shortly after administration and be the mechanism, which 
allows a normalisation of MAP. In another study, hypertensive rats exposed to instilled 
UFPs increased fH and MAP, whereas the normal rats did not respond (Gordon et al., 
1998). The authors therefore hypothesized that inhaled PM causes systemic effects by 
evoking a stress that may compensated in healthy individuals, but that severely disrupts 
homeostatic processes in individuals with cardiovascular or pulmonary diseases (Gordon et 
al., 1998). This underpins the importance of future studies on the cardiovascular effects of 
NPs during disease states, because most patients to receive NP are likely to suffer from 
various diseases, including hypertension.  
The cause of the NP effect –endothelial stress?  
The effects of NPs on the cardiovascular system have been proposed to relate to the 
formation of oxidative stress that impairs normal endothelial function (Behrendt et al., 
2002). We have shown in the present study that the γ-Fe2O3 NPs are taken up by 
endothelial cells, particularly in liver and kidney, and that the small mesenteric arteries 
exposed short-term to these γ-Fe2O3 NPs failed to obtain the maximal force development 
when stimulated with NA. This may support the proposed hypothesis. The arteries used 
were small enough to be regarded as resistance arteries and are therefore considered to be 
of importance for the regulation of flow distribution (Mulvany and Halpern, 1977). The 
main observation is that the major endothelial-dependent relaxing pathways seem to be 
intact, though the contractile response to NA is decreased. This may be due to the 
development of oxidative stress. Mo et al. (2009) showed that UFPs, at a non-toxic dose, 
induced reactive oxygen species (ROS) generation in mouse pulmonary micro vascular 
endothelial cells. In the present study, both the short-term (24h and 72h) exposure in vivo 
to γ-Fe2O3 NPs and the 0.5h in vitro exposure affected the endothelial function, so 
generation of ROS seems unlikely during our experimental conditions due to the short time 
of exposure. Therefore, the effects on endothelial function observed here may be explained 
by an uptake of the NP in the endothelial cells. Thus, endothelial cells, which line the inner 
surface of blood vessels, are in direct contact with these particles, emphasizing the 
relevance of particle-endothelial interactions. If a pro-inflammatory stimulation of 
endothelial cells by nano-scaled particles occurs in vivo, a chronic inflammation (such as 
granulomatosis) could be a possible consequence. Since endothelial proliferation is a 
prerequisite for blood vessel formation (e.g. during wound healing), an impairment of 
endothelial proliferation could indicate a reduced capacity for blood vessel formation 
(angiogenesis) in vivo (Peters et al., 2004). 
We demonstrate that intravenous injections of γ-Fe2O3 NPs NPs cause an acute 
reduction in MAP, compensated for by cardiovascular adjustments or a termination of the 
NP effect. 
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